Email this article DIAGNOSING OF DRUG TOXIDERMIA CAUSED BY NUROFEN BY THE METHOD OF BARIUM SULFATE STIMULATED LUMINOL-DEPENDENT CHEMILUMINESCENCE OF LEUKOCYTES
- Authors: Teplyuk N.P1, Kadyrova Z.S.1
-
Affiliations:
- Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 22, No 1-2 (2019)
- Pages: 39-45
- Section: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/42935
- DOI: https://doi.org/10.17816/dv42935
- ID: 42935
Cite item
Full Text
Abstract
Objective. to determine the general patterns of changes barium sulfat stimulated luminol-dependent chemiluminescence of leukocytes in patients with drug toxidermia caused by taking nurofen (ibuprofen) and in the control group, as well as to select NSAIDs for replacement therapy. Material and methods. the object of the study were 15 patients (11 women and 4 men) with drug toxidemia (7 patients with toxidermia, 4 patients with acute urticaria) developed after taking nurofen (ibuprofen), and a control group consisting of 15 people (9 women and 6 men) who were not intolerant to this drug. The study participants were aged 18 to 75 years, median - 53. Measurement of barium sulfate-stimulated luminol-dependent chemiluminescence (SLCL) of leukocytes was performed on the Lum-100 chemiluminometer. The calculations were carried out using the computer program PowerGraph. Results. during the influence of nurofen (ibuprofen) on the blood of patients with intolerance to this drug and the control group dose-dependent changes in SLCL were observed. The relative intensity and relative light sum of blood SLCL in patients was significantly lower than in the control group at all studied drug concentrations (p < 0.01). SLCL indices in different forms of LT do not differ significantly (p < 0.01). The relative intensity and relative light sum of blood SLCL in patients were significantly lower in samples with the drug that caused the development of the disease than with drugs for replacement therapy (p < 0.01). At minimum concentration, there are no significant differences (p > 0.05).
Full Text
##article.viewOnOriginalSite##About the authors
N. P Teplyuk
Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University)119435, Moscow, Russian Federation
Zilola S. Kadyrova
Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: rose1604@yandex.ru
postgraduate of the Department of skin and venereal diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russian Federation 119435, Moscow, Russian Federation
References
- Уджуху В.Ю., Медведева А.С., Иванокова М.А. Клинико-иммунологическая характеристика токсидермий, в том числе с явлениями вторичной пиодермии. Российский журнал кожных и венерических болезней. 2012; 5: 44-6.
- Blanca-Lopez N., Cornejo-Garcia J.A., Perez-Alzate D., Perez-Sanchez N., Plaza-Seron M.C., Dona I., et al. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in children and adolescents: selective reactions. J. Investig. Allergol. Clin. Immunol. 2015; 25(6): 385-95.
- Suchak R., Benson K., Swale V. Statin-induced Ro/SSA-positive subacute cutaneous lupus erythematosus. Clin. Exp. Dermatol. 2007; 32(5): 589-91.
- Тузлукова Е.Б., Царев С.В., Лусс Л.В., Феденко Е.С., Елисютина О.Г. Лекарственная аллергия и другие виды осложнений лекарственной терапии: от классификации к диагностике. Аллергология. 2008; 2: 27-8.
- Файзуллина Е.В., Давыдов Ю.В. Лекарственная токсикодермия: лечение и профилактика. Практическая медицина. 2013; 1: 9-12.
- Чаусова С.В., Бондарева Г.П., Усанова Е.А. Влияние диклофенака натрия на оксидантные функции полиморфно-ядерных лейкоцитов периферической крови здоровых доноров и больных с повышенной чувствительностью к диклофенаку. Медицинский вестник Башкортостана. 2014; 9(1): 73-6.
- Хаитов Р.М., Ильина Н.И. Федеральные клинические рекомендации по диагностике и лечению лекарственной аллергии. М.: Фармарус Принт Медиа; 2014.
- Czech W., Barbisch M., Tenscher K. Chemotactic 5-oxo-eicosatetraenoic acidsinduce oxygen radical production, Ca2+-mobilization, and actin reorganization in human eosinophils via a pertussis toxin-sensitive G-protein. J. Invest. Dermatol. 1997; 108(1): 108-12.
- Чаусова С.В. Особенности оксидантной активности фагоцитов периферической крови больных с непереносимостью нестероидных противовоспалительных препаратов и обоснование патогенетической терапии непереносимости нестероидных противовоспалительных препаратов: Автореф. дис. … д-ра мед. наук: 14.03.06. Москва; 2016: 3-6. http://www.rsmu.ru/fileadmin/rsmu/img/about_rsmu/disser/5/d_chausova_sv.pdf
- Теплюк Н.П., Кадырова З.С. Разнообразие клинических проявлений лекарственной токсидермии у больных, находившихся на лечении в клинике кожных и венерических болезней им. В.А. Рахманова ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России. Современные проблемы науки и образования. 2019. https://science-education.ru/pdf/2019/3/28900.pdf
- Бизунок Н.А. Влияние противовоспалительных средств на фагоцитарную генерацию оксидантов. Белорусский медицинский журнал. 2002; 2: 56-58.
- Dai H.F., Wang X.W., Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat. Dis. Int. 2009; 8(1): 11-6.
- Takayama F., Egashira T., Yamanaka Y. Effect of diclofenak, a non-steroidal anti-inflammatory drug, on lipid peroxidation caused by ischemia-reperfusion in rat liver. Jpn J. Pharmacol. 1994; 64(2): 71-8.
- Cornejo-Garcia J.A., Jurado-Escobar R., Dona I., Perkins J.R., Agundez J.A., Garcia-Martin E., et al. The genetics of drug hypersensitivity reactions. J. Investig. Allergol. Clin. Immunol. 2016; 26(4): 222-32.
